Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

Autor:	Maureen J.B. Aarts, R van Rijn, M Schouwenburg, D Piersma, J.S. van der Hoeven, Marieke W. J. Louwman, G. Vreugdenhil, Rutger H. T. Koornstra, A Jochems, F van den Berkmortel, Michel W.J.M. Wouters, A.J.M. van den Eertwegh, Wim H. J. Kruit, B Leeneman, Geke A. P. Hospers, Gerard Groenewegen, H Kapiteijn, J.W.B. de Groot, A.C.J. van Akkooi, M Franken, A.J. ten Tije, M van Zeijl, J.B.A.G. Haanen, C Uyl de Groot
Rok vydání:	2016
Předmět:	Oncology medicine.medical_specialty business.industry Health Policy Internal medicine Public Health Environmental and Occupational Health medicine Real world outcomes In patient Ipilimumab business Advanced melanoma medicine.drug
Zdroj:	Value in Health. 19:A708-A709
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fb2a99432380e5ad3ee80b71cc01bc40 https://doi.org/10.1016/j.jval.2016.09.2077 Zobrazit plný text záznamu Full Text from ScienceDirect